SCHEMBL3572176

SCHEMBL3572176

O=C(NC1CCCCC1)C1=C(c2ccccc2)c2ccc(O)cc2C1=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 2/20 0.50
ESR2 Q92731 2/20 0.50
ALDH1A1 P00352 2/20 0.50
LMNA P02545 2/20 0.50
KMT2A Q03164 2/20 0.50
MEN1 O00255 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
GAA P10253 1/20 0.48
MAOB P27338 2/20 0.46
FGFR1 P11362 1/20 0.46
FGFR2 P21802 1/20 0.46
FGFR4 P22455 1/20 0.46
FGFR3 P22607 1/20 0.46
S1PR1 P21453 1/20 0.46
TYR P14679 2/20 0.45
NPC1 O15118 4/20 0.44
RAB9A P51151 3/20 0.44
KDM4E B2RXH2 1/20 0.44
HPGD P15428 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4656549 0.97 FGFR1 (0.48) ESR1ESR2ALDH1A1LMNAKMT2A
SCHEMBL4656551 0.90 PPARG (0.45) ESR1ESR2ALDH1A1LMNAKMT2A
SCHEMBL4823811 0.81 PPARG (0.68) ESR1ESR2NPC1RAB9A
SCHEMBL3577620 0.79 PPARG (0.62) ALDH1A1KMT2AMEN1SMN1; SMN2MAOB
SCHEMBL3575957 0.77 FGFR1 (0.70) ESR1ESR2ALDH1A1LMNAKMT2A
SCHEMBL3574590 0.75 PPARG (0.73) NPC1RAB9AKDM4ECNR1CNR2
SCHEMBL3578768 0.74 FGFR1 (0.74) ESR1ESR2FGFR1FGFR2FGFR4
SCHEMBL4656306 0.71 FGFR1 (0.68) ESR1ESR2FGFR1FGFR2FGFR4
Isopropylamine SCHEMBL3581231 0.70 FGFR1 (0.63) ESR1ESR2ALDH1A1LMNAKMT2A
SCHEMBL3570952 0.68 PPARG (0.74) ESR1ESR2ALDH1A1LMNAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7745439-B2 Indene derivatives and process for the preparation thereof KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2010-06-29 US disclosed
US-20070225288-A1 Indene Derivatives and Process for the Preparation Thereof JEIL PHARM. CO., LTD. (KR) 2007-09-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070225288-A1 Indene Derivatives and Process for the Preparation Thereof INSR, GPR119, PPARA ESR1 236/4885ESR2 168/4885ALDH1A1 773/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.